| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000269924.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.037504951 |
Resistant |
| ENSG00000269924.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.034295441 |
Sensitive |
| ENSG00000269924.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.047056952 |
Sensitive |
